Related Experiment Video
Updated: Jun 4, 2026
08:03
The Detection of 5-Hydroxymethylcytosine in Neural Stem Cells and Brains of Mice
Published on: September 19, 2019
DNA methylation in repetitive elements and Alzheimer disease
V Bollati1, D Galimberti, L Pergoli
1Center of Molecular and Genetic Epidemiology, Department of Environmental and Occupational Health, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy. valentina.bollati@unimi.it
Brain, Behavior, and Immunity
|February 8, 2011
Summary
LINE-1 DNA methylation in blood is elevated in Alzheimer's disease (AD) patients and correlates with cognitive function. This epigenetic marker may aid in understanding AD progression and risk stratification.
Area of Science:
- Epigenetics
- Neuroscience
- Molecular Biology
Background:
- Epigenetics, particularly DNA methylation, is implicated in Alzheimer's disease (AD) pathogenesis.
- Repetitive elements like LINE-1 contribute significantly to global DNA methylation patterns.
- The methylation status of repetitive elements in the blood of AD patients remains under-investigated.
Purpose of the Study:
- To investigate the methylation status of repetitive elements (Alu, LINE-1, SAT-α) in the blood of AD patients.
- To explore the association between repetitive element methylation and AD.
- To assess the potential of these epigenetic markers for AD risk stratification.
Main Methods:
- Quantitative bisulfite-PCR pyrosequencing was employed.
- Methylation levels of Alu, LINE-1, and SAT-α sequences were evaluated.
- Analysis included 43 AD patients and 38 healthy donors, with adjustments for age and gender.
Main Results:
- LINE-1 methylation was significantly increased in AD patients compared to healthy volunteers (83.6% vs. 83.1% 5mC, p=0.05).
- Higher LINE-1 methylation levels were observed in AD patients with better cognitive performance (MMSE>22) compared to those with worse performance (MMSE≤22, p=0.05).
- No significant difference was found for Alu and SAT-α methylation levels between groups.
Conclusions:
- LINE-1 methylation in blood may serve as a potential biomarker for Alzheimer's disease.
- Increased LINE-1 methylation is associated with AD and cognitive status.
- Further research is needed to understand the dynamic role of DNA methylation in AD progression.
More Related Videos
Related Concept Videos
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
02:05Duplication of Chromatin Structure
The process of chromosome duplication during cell division requires genome-wide disruption and re-assembly of chromatin. The chromatin structure must be accurately inherited, reassembled, and maintained in the daughter cells to ensure lineage propagation.
The basic unit of the chromatin is the nucleosome, consisting of DNA wrapped around octameric histone proteins and short stretches of linker DNA separating individual nucleosomes. The histone proteins within the nucleosome have their...
The basic unit of the chromatin is the nucleosome, consisting of DNA wrapped around octameric histone proteins and short stretches of linker DNA separating individual nucleosomes. The histone proteins within the nucleosome have their...